Get the Weekly Intelligence Brief — top committee picks every Sunday.

HSIC vs LFST

Henry Schein vs LifeStance Health Group, Inc. — AI-powered side-by-side comparison
HSIC
Henry Schein
67
Buy
VS
LFST
LifeStance Health Group, Inc.
53
Watch
MetricHSICLFST
AI Score 67 53
Price $89.16 $11.51
P/E Ratio 25.77× 88.33×
ROE 12.3% 0.6%
Revenue Growth YoY
Gross Margin 30.3% 25.8%
Debt / Equity 1.21× 0.14×
Dividend Yield 0.0% 0.0%
RSI (14) 59.4 62.9
Beta 0.808 1.138
Expected Upside +0.8%

AI Committee View

Current Innellis committee reasoning for HSIC versus LFST.
HSIC leads by 14 points.

HSIC scores 67/100 (Buy) versus LFST at 53/100 (Watch).

HSIC Committee View
75% agreement
4 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.

Bull Case
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
LFST Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -12.8% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • P/E of 196.0 is expensive by classic value standards — Value
  • ROE of only 1.6% -- cheap may mean cheap for a reason — Value
  • Revenue declining -12.8% YoY -- this is not a growth story right now — Growth
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
HSIC Full Analysis LFST Full Analysis